| Bioactivity | CPA inhibitor (Carboxypeptidase inhibitor; compound 5) is a potent carboxypeptidase A (CPA) inhibitor with a Ki of 0.32 μM[1]. | ||||||||||||
| Target | Ki: 0.32 μM (CPA) | ||||||||||||
| Name | CPA inhibitor | ||||||||||||
| CAS | 223532-02-3 | ||||||||||||
| Formula | C18H19NO4 | ||||||||||||
| Molar Mass | 313.35 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. D H Kim, et al. First hydroxamate inhibitors for carboxypeptidase A. N-acyl-N-hydroxy-beta-phenylalanines. Bioorg Med Chem Lett. 1999 Mar 8;9(5):691-6. |
CPA inhibitor
CAS: 223532-02-3 F: C18H19NO4 W: 313.35
CPA inhibitor (Carboxypeptidaseinhibitor; compound 5) is a potent carboxypeptidase A (CPA) inhibitor with a Ki of 0.32
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.